Healthcare & Life Sciences Private Equity Deal Tracker: WindRose Completes Sale Of MyNEXUS To Anthem

WindRose Health Investors has announced it has completed the sale of myNEXUS to health benefits company Anthem.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

WindRose Health Investors has announced it has completed the sale of myNEXUS to health benefits company Anthem.

myNEXUS, based in Brentwood, Tenn., is a post-acute benefits management company. The company states that it delivers integrated clinical support services for Medicare Advantage members in 20 states.

WindRose, based in New York, pursues control equity investments in healthcare companies. Founded in 2000, the firm invests in a broad range of industry segments, including outsourced services to payors and health systems, technology-enabled services, healthcare providers and value-added distribution.

Terms of the transaction were not disclosed.

WindRose's announced its intention to sell myNEXUS to Anthem in March.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More